These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4902056)

  • 1. [The influence of pharmaceutical and physico-chemical factors of drugs on the result of clinical trials: chloramphenicol palmitate].
    van Oudtshoorn MC; Potgieter FJ; Koeleman HA; Pantonowitz LD
    S Afr Med J; 1969 Nov; 43(45):1375-6. PubMed ID: 4902056
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of chloramphenicol in children, rhesus monkeys, and cats after administration of chloramphenicol palmitate suspension.
    Banerjee S; Bandyopadhyay A; Bhattacharjee RC; Mukherjee AK; Halder AK
    J Pharm Sci; 1971 Jan; 60(1):153-5. PubMed ID: 4994065
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of new active forms of chlormphenicol palmitate in the treatment of typhoid and paratyphoid fevers in children.
    Hegazy MR; Abdel-Wahab MF; Kaddah N; Hathoot S; Wishahy A
    J Egypt Med Assoc; 1971; 54(1):35-46. PubMed ID: 5002925
    [No Abstract]   [Full Text] [Related]  

  • 4. Absorption and dissolution characteristics of 14 different oral chloramphenicol preparations tested on healthy human male subjects.
    Bel H; Johansen H; Lunde PK; Andersgaard HA; Finholt P; Midtvedt T; Holum E; Martinussen B; Aarnes ED
    Pharmacology; 1971; 5(2):108-20. PubMed ID: 5570924
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preparation, hydrolysis and resorption of chloramphenicol palmitate-suspensions].
    Braeckman P; van Severen R; Dony J; de Roeck A
    Pharmazie; 1966 Dec; 21(12):757-60. PubMed ID: 6001165
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of manufacturing conditions and physical properties of sulfonamide and palmitate suspensions of chloramphenicol on their stability and resorption].
    Moës A
    Mem Acad R Med Belg; 1969; 5(6):797-899. PubMed ID: 5360537
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of tween 8OR concentration on the particle dimension, rheologic properties and physical stability of chloramphenicol palmitate suspensions].
    Moës A
    J Pharm Belg; 1970; 25(5):409-22. PubMed ID: 5494311
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorption and excretion of two chloramphenicol products in humans after oral administration.
    Bartelloni PJ; Calia FM; Minchew BH; Beisel WR; Ley HL
    Am J Med Sci; 1969 Sep; 258(3):203-8. PubMed ID: 5824862
    [No Abstract]   [Full Text] [Related]  

  • 9. A pharmacologic study of chloramphenicol in cattle.
    Sisodia CS; Dunlop RH; Gupta VS; Taksas L
    Am J Vet Res; 1973 Sep; 34(9):1147-51. PubMed ID: 4747035
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bioavailability of chloramphenicol palmitate suspension].
    Morasso MI; Hirmas E; Firmani E; Pezoa R; Cid E
    Pharm Acta Helv; 1980; 55(10):270-3. PubMed ID: 7454734
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of chloramphenicol acid succinate therapy of induced typhoid fever and rocky mountain spotted fever.
    DuPont HL; Hornick RB; Weiss CF; Snyder MJ; Woodward TE
    N Engl J Med; 1970 Jan; 282(2):53-7. PubMed ID: 4982445
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative studies of chloramphenicol activity, fate and absorption in different suspensions.
    Galal EE; Raggal MH; Kamel HH; Sabbagh H; Mahmoud MA; Azzam AB
    J Egypt Med Assoc; 1965; 48():Suppl:89-97. PubMed ID: 5873680
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chloramphenicol in human bacteriological infections. Bacteriological and clinical observations].
    Saraceni G; Diana L; Lechi A; Sgoifo E; Fameli O
    Recenti Prog Med; 1968 Feb; 44(2):132-53. PubMed ID: 4909755
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of chloramphenicol on the mother and baby. II. Transfer, absorption, excretion and adverse effects of chloramphenicol in the newborn infant].
    Kunii K
    Jpn J Antibiot; 1970 Aug; 23(4):363-78. PubMed ID: 5312787
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ambulatory prescription of chloramphenicol].
    Schneider I; Walther H
    Z Arztl Fortbild (Jena); 1970 Jun; 64(11):550-6. PubMed ID: 5520098
    [No Abstract]   [Full Text] [Related]  

  • 16. Chloramphenicol metabolism in the phenobarbital-induced rat. Comparison with thiamphenicol.
    Bella DD; Marca G; Ferrari V; Bonanomi L
    Biochem Pharmacol; 1968 Dec; 17(12):2381-90. PubMed ID: 5720346
    [No Abstract]   [Full Text] [Related]  

  • 17. Rate studies on dissolution and enzymatic hydrolysis of chloramphenicol palmitate.
    Andersgaard H; Finholt P; Gjermundsen R; Hoyland T
    Acta Pharm Suec; 1974 Jun; 11(3):239-48. PubMed ID: 4839734
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of chronic administration of centrally acting compounds on chloramphenicol metabolism in schizophrenic patients.
    Watanabe A
    Pharmacology; 1974; 11(4):253-6. PubMed ID: 4156595
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and biological study of a new preparation with a chloramphenicol base].
    Fiorentino F; Sasso G; Pane G; Maio G; Scioli C
    Rass Int Clin Ter; 1971 Dec; 51(23):1415-21. PubMed ID: 5142826
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of chloramphenicol palmitate in pharmaceutical suspensions.
    Banerjee S; Chakrabarti K; Haldar AK
    J Pharm Sci; 1973 Nov; 62(11):1841-4. PubMed ID: 4585986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.